AmMetLife, in seeking forward-thinking partnerships, ties-up with Heydoc Health to launch Malaysia’s first data-driven drug optimisation program

• Escalating cost of healthcare can no longer be addressed by traditional methods alone
• AmMetLife aims to leverage technology to ensure affordability without compromising care

AmMetLife Insurance Bhd has signed a MoU with Heydoc Health Sdn Bhd to launch Malaysia’s first drug optimisation program, leveraging data-driven insights and technology to improve the affordability and long-term sustainability of healthcare coverage. According to AmMetLife, the collaboration aims to help customers access the right medication at fair prices, without comprising quality or continuity of care.

Rangam Bir, CEO of AmMetLife, said: “The escalating cost of healthcare is a challenge that can no longer be addressed by traditional methods alone. At AmMetLife, we are committed to forward-thinking partnerships that protect our customers today and future-proof our health and medical insurance solutions. Working with Heydoc Health allows us to leverage technology to ensure affordability without compromising care.”

Dr Raymond Choy, CEO and founder of Heydoc Health, said: “We are excited to partner with AmMetLife on this initiative, which marks a major step toward achieving fairer, smarter healthcare financing in Malaysia. By applying data analytics, we can deliver value-based care and patients benefit from improved access to affordable, high-quality treatment.”

By analysing prescription trends and generic substitution opportunities, Heydoc Health said it has reduced medication costs while maintaining clinical quality and safety. This in turn helps insurers like AmMetLife design affordable, optimised corporate health plans, providing equal access to all customers.

Heydoc Health will integrate with AmMetLife’s claims and prescription datasets through a secure, anonymized data-sharing framework under strict compliance with Malaysia’s Personal Data Protection Act (PDPA). No personally identifiable information (PII) is shared; only aggregated historical data relevant to utilisation and pricing trends is used. This allows Heydoc Health to build predictive models for future claims optimization and value-based plan design.

Building such a predictive model means using AI/data analytics to simulate future claims, then structuring insurance and drug benefits so that patients get the right drugs at fair prices while the insurer manages risk more sustainably.

The program, the first between Heydoc Health and an insurance company, with  more tie-ups in the pipeline, will roll out in phases, starting with high-utilisation medications and expanding to a wider range over time, delivering consistent savings and supporting the long-term sustainability of healthcare coverage for Malaysians.

Examples of high-utilisation medications are, analgesics (paracetamol, ibuprofen), anti-inflammatory (naproxen, diclofenec), GERD (ezomeprazole, pantoprazol), URTI (cetirizine, loratadine) and antibiotics (amoxicillin).

A digital heath startup, Heydoc Health offers various healthcare infrastructure solutions including telehealth and electronic prescriptions (via DOC2US), smart drug formulary and pricing optimization (via enSURE), and digital outpatient programs such as FutureK.